​

Funding Round

Series C - Spinifex Pharmaceuticals

Series C - Spinifex Pharmaceuticals

Investment Firm

Overview

Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.

Announced Date

Apr 10, 2014

Closed on Date

Apr 10, 2014

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

Novo Holdings

Novo Holdings

Novo Holdings is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and secondary_market and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorUniseed
Participant InvestorNovo Holdings
Participant InvestorBrandon Capital
Participant InvestorGBS Ventures
Participant InvestorCanaan Partners

Round Details and Background

Spinifex Pharmaceuticals raised $45000000 on 2014-04-10 in Series C

Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 26, 2005
Series A - Spinifex Pharmaceuticals
3-2.5M
Sep 03, 2008
Series A - Spinifex Pharmaceuticals
3-10.0M
Apr 10, 2014
Series C - Spinifex Pharmaceuticals
6-45.0M
Aug 23, 2011
Series B - Spinifex Pharmaceuticals
4-19.2M

Recent Activity

There is no recent news or activity for this profile.